Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction

Clinical trial NCT02246595 · COMPLETED

Trial details

NCT number: NCT02246595
Sponsor: InflaRx GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Sepsis Septic Shock

Start date: 2014-04-01
Primary completion: 2015-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.